Product Overview
Tesamorelin is a synthetic research compound supplied by Arche Research as a lyophilized material for lawful laboratory, analytical, and non-clinical research. Multiple nominal quantities are available through the strength selector on this page.
Research Context
Tesamorelin has been examined in published preclinical and clinical research involving its activity as an analogue of growth hormone-releasing hormone (GHRH) that stimulates the synthesis and secretion of endogenous growth hormone (GH). Investigations have primarily focused on its pharmacokinetic profile, pituitary receptor interaction, and downstream effects on visceral adipose tissue (VAT) reduction, lipid metabolism, and body composition in clinical trial settings. The references provided below are included to identify relevant scientific literature and do not constitute product-use, medical, or administration guidance.
Research References
- Falutz J, et al. “Metabolic effects of a growth hormone-releasing factor in patients with HIV.” The New England Journal of Medicine. 2007;357(23):2359-2370. DOI: 10.1056/NEJMoa072070.
- Stanley TL, Grinspoon SK. “Effects of growth hormone-releasing hormone on visceral fat, metabolic indices, and cardiovascular risk in abdominal obesity.” The Journal of Clinical Endocrinology & Metabolism. 2014;99(8):2838-2846. DOI: 10.1210/jc.2014-1610.
